Weight changes are reported, but many users experience mild weight loss initially due to decreased appetite. Long-term weight gain is less common with fluoxetine than with some other antidepressants.
Fluoxetine passes into breast milk in low concentrations. While some infants may be exposed, most studies have not shown serious adverse effects. Discuss the risks and benefits with your prescriber.
Improvement in mood often begins after 2-4 weeks, although full therapeutic effect may take up to 8 weeks.
If you remember within 12 hours, take the missed capsule. If more time has passed, skip it and continue with your regular schedule.
Yes. St. John’s Wort, 5-HTP, and other serotonergic supplements can increase the risk of serotonin syndrome. Always inform your pharmacist about any supplements you use.
Fluoxetine can alleviate the emotional and physical symptoms of PMDD by stabilising serotonin levels during the luteal phase of the menstrual cycle.
Yes, fluoxetine is widely available as a generic capsule in 10 mg, 20 mg, and 60 mg strengths, often at a lower cost than branded products.
Yes, but carry the prescription label and a copy of the prescribing doctor's note. Some countries may require additional documentation, so check local regulations before travel.
Fluoxetine is not a controlled substance and does not typically trigger a positive result on standard workplace drug screens.
Combining fluoxetine with other serotonergic agents (e.g., other SSRIs, SNRIs, MAOIs) increases the risk of serotonin syndrome and is generally avoided unless specifically directed by a specialist.
Fluoxetine is an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is available in capsule form in strengths of 10 mg, 20 mg, and 60 mg. In the United Kingdom, fluoxetine is a prescription-only medicine regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). While marketed as a generic drug, it is also sold under several brand names, including Prozac, Sarafem, and Fontex.
Fluoxetine increases the amount of serotonin-the neurotransmitter that influences mood, anxiety, and sleep-by blocking its reabsorption (reuptake) into nerve cells. Higher serotonin levels enhance communication between neurons in brain pathways that regulate emotional state. The drug is well absorbed from the gastrointestinal tract, reaches peak plasma concentrations in 6-8 hours, and has a long elimination half-life (about 4-6 days for the parent compound and up to 16 days for its active metabolite, norfluoxetine). This prolonged half-life contributes to once-daily dosing and a smoother withdrawal profile compared with shorter-acting SSRIs.
Fluoxetine has received marketing authorization from the MHRA for the following adult indications:
These approvals are based on randomized controlled trials demonstrating improvement in symptom severity scales and functional outcomes. Fluoxetine is typically prescribed to adults of all ages; specific pediatric dosing follows separate guidelines and is not covered in this adult-focused article.
Some clinicians prescribe fluoxetine for conditions that lack formal approval but have supporting evidence in peer-reviewed literature.
Disclaimer: Off-label use is not approved by the MHRA and should only be considered under the supervision of a qualified healthcare professional after a personalized risk-benefit assessment.
Ideal candidates are adults with a confirmed diagnosis of one of the approved indications and no contraindicating medical conditions.
If you have medical conditions not listed here, consult a pharmacist or prescriber for personalized guidance.
Major:
MAO inhibitors - may cause hypertensive crisis or serotonin syndrome.
Pimozide, thioridazine - increased plasma concentrations leading to cardiac toxicity.
Moderate:
Warfarin - may enhance anticoagulant effect; monitor INR.
Non-SSRIs (e.g., tramadol, linezolid) - additive serotonergic effect, consider dose adjustment.
Fluoxetine inhibits CYP2D6, potentially raising levels of drugs metabolised by this enzyme (e.g., codeine, certain antipsychotics).
When in doubt, always disclose all current medications, supplements, and herbal products to your prescriber.
Standard dosing:
Initial dose typically 20 mg once daily (taken in the morning).
For certain indications (e.g., bulimia nervosa), a lower start of 10 mg may be used.
Dose may be increased in 20 mg increments up to a maximum of 60 mg per day, based on clinical response and tolerability.
Special populations:
Renal impairment: No routine dose adjustment required unless severe.
Hepatic impairment: Start at 10 mg daily; avoid exceeding 20 mg unless closely monitored.
Elderly: Consider starting at 10 mg daily, titrating slowly.
Administration:
Swallow capsules whole with water; do not chew or crush.
Can be taken with or without food; taking with breakfast may reduce initial nausea.
Missed dose: Take the missed dose as soon as remembered if it is within 12 hours; otherwise, skip and resume the regular schedule. Do not double the dose.
Overdose: Symptoms may include tremor, vomiting, seizures, or cardiac arrhythmias. Seek emergency medical care; activated charcoal may be considered if presentation is early. No specific antidote is available.
Discontinuation: Due to fluoxetine’s long half-life, abrupt cessation is generally safe, but a gradual taper over several weeks can minimise discontinuation syndrome (e.g., flu-like symptoms, irritability).
Patients should contact their prescriber if they notice worsening depression, emergence of suicidal thoughts, or any serious adverse reactions.
This article provides educational information about fluoxetine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
